# The COMBINE-AF Trial

> **NCT07633509** · NA · NOT_YET_RECRUITING · sponsor: **Yunlong Wang** · enrollment: 430 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)
- Atrial Fibrillation Catheter Ablation

## Interventions

- **PROCEDURE:** Linear ablation of mitral isthmus and tricuspid isthmus
- **DRUG:** Ethanol
- **PROCEDURE:** Radiofrequency Ablation Catheter

## Key facts

- **NCT ID:** NCT07633509
- **Lead sponsor:** Yunlong Wang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-27
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 430 (ESTIMATED)
- **Last updated:** 2026-07-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07633509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07633509, "The COMBINE-AF Trial". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07633509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*